Webinars

Are you looking to maximize the value of site-centric services in your clinical trials? Listen to our webinar to discover how Ergomed's innovative Site Manager Model can help.

Patient-focused drug development (PFDD) is a systematic approach to help ensure that patients' experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation.

Sponsors must be able to balance the need for efficiency and inclusivity on the path to seeking drug approval for rare cancer. Focusing on this topic, our oncology experts will share valuable insights and strategies for developing and operationalizing clinical trials in this space in this free educational webinar.

This webinar will explore the strategic considerations and innovations for accelerating the drug development of rare diseases. Our listeners will also understand the importance of patient- and site-centric solutions in aiding this process as well as gain insight into the Ergomed Rare Disease Innovation Center.

In this oncology-focused webinar, Ergomed Vice President of Therapeutic Strategy for Oncology, Debra Kientop, shares with our listeners some valuable insights on how to incorporate AI and technology into oncology clinical development, focusing on how to identify the right partners and considerations that go beyond the technology.

This new webinar aims for our regulatory experts to present and provide our listeners with a good understanding of the regulatory framework for compassionate use.